Investigating genotype–phenotype relationships in Rett syndrome using an international data set
暂无分享,去创建一个
W. Kaufmann | H. Leonard | D. Ravine | M. Pineda | N. de Klerk | B. Ben-Zeev | A. Percy | A. Bebbington | M. Pineda | N. Yatawara | S. Fyfe | A. Anderson | N. D. Klerk | Alison Anderson
[1] R. Fisher. On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .
[2] T. Charman,et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation , 2006, Journal of Medical Genetics.
[3] Carol Bower,et al. Rett syndrome in Australia: a review of the epidemiology. , 2006, The Journal of pediatrics.
[4] R. Prescott,et al. Predictive value of the early clinical signs in Rett disorder , 2005, Brain and Development.
[5] R. Hastings,et al. Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype–phenotype associations in Rett syndrome , 2005, European Journal of Human Genetics.
[6] T. Matsuishi,et al. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms , 2005, Brain and Development.
[7] H. Leonard,et al. InterRett—The application of bioinformatics to International Rett syndrome research , 2005, Annals of human biology.
[8] H. Smeets,et al. Rett syndrome in females with CTS hot spot deletions: A disorder profile , 2005, American journal of medical genetics. Part A.
[9] Linda Slack-Smith,et al. How Can the Internet Help Parents of Children With Rare Neurologic Disorders? , 2004, Journal of child neurology.
[10] R. Cantor,et al. Phenotypic manifestations of MECP2 mutations in classical and atypical rett syndrome , 2004, American journal of medical genetics. Part A.
[11] J Christodoulou,et al. Refining the phenotype of common mutations in Rett syndrome , 2004, Journal of Medical Genetics.
[12] H. Smeets,et al. Rett syndrome in adolescent and adult females: Clinical and molecular genetic findings , 2003, American journal of medical genetics. Part A.
[13] J. Christodoulou,et al. InterRett and RettBASE: International Rett Syndrome Association Databases for Rett Syndrome , 2003, Journal of child neurology.
[14] Andrew J. Grimm,et al. RettBASE: The IRSA MECP2 variation database—a new mutation database in evolution , 2003, Human mutation.
[15] T. Matsuishi,et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? , 2003, Journal of medical genetics.
[16] N. Laing,et al. Effects of MECP2 mutation type, location and X‐inactivation in modulating Rett syndrome phenotype , 2003, American journal of medical genetics. Part A.
[17] M. Msall,et al. Describing the phenotype in Rett syndrome using a population database , 2003, Archives of disease in childhood.
[18] F. Hanefeld,et al. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[19] P. Huppke,et al. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. , 2002, Neuropediatrics.
[20] E. Hoffman,et al. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. , 2002, Mental retardation and developmental disabilities research reviews.
[21] E. Monrós,et al. Rett syndrome in Spain: mutation analysis and clinical correlations , 2001, Brain and Development.
[22] T. Matsuishi,et al. Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech , 2001, Brain and Development.
[23] H. Leonard,et al. Using the Internet to pilot a questionnaire on childhood disability in Rett syndrome. , 2001, Child: care, health and development.
[24] Masaya Segawa,et al. Guidelines for reporting clinical features in cases with MECP2 mutations , 2001, Brain and Development.
[25] E. Hoffman,et al. MeCP2 mutations in children with and without the phenotype of Rett syndrome , 2001, Neurology.
[26] L. Peltonen,et al. MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features , 2001, Neurology.
[27] A. Silahtaroglu,et al. MECP2 mutations in Danish patients with Rett syndrome: High frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern , 2001, European Journal of Human Genetics.
[28] H. Zoghbi,et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes , 2000, Annals of neurology.
[29] D. Cooper,et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. , 2000, Human molecular genetics.
[30] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[31] J. Christodoulou,et al. A population‐based approach to the investigation of osteopenia in Rett syndrome , 1999, Developmental medicine and child neurology.
[32] T. Perneger. What's wrong with Bonferroni adjustments , 1998, BMJ.
[33] B. Hagberg. Clinical Delineation of Rett Syndrome Variants , 1995, Neuropediatrics.
[34] Diagnostic criteria for rett syndrome , 1988 .
[35] F. Yates. Contingency Tables Involving Small Numbers and the χ2 Test , 1934 .
[36] R. Fisher. 036: On a Distribution Yielding the Error Functions of Several Well Known Statistics. , 1924 .
[37] R. Fisher. 019: On the Interpretation of x2 from Contingency Tables, and the Calculation of P. , 1922 .